Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration

This study investigated whether the interval of monitoring at-risk, fellow eyes of patients with unilateral neovascular age-related macular degeneration (nAMD) has any bearing on the severity of the disease at the time of diagnosis. The study comprised a retrospective, cross-sectional comparative ca...

Full description

Bibliographic Details
Main Authors: Oluchukwu Onwuka, Jackson L. Saddemi, Fatma Sema Akkan Aydoğmuş, Claudia C. Lasalle, David J. Ramsey
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/2/385
_version_ 1797619867828879360
author Oluchukwu Onwuka
Jackson L. Saddemi
Fatma Sema Akkan Aydoğmuş
Claudia C. Lasalle
David J. Ramsey
author_facet Oluchukwu Onwuka
Jackson L. Saddemi
Fatma Sema Akkan Aydoğmuş
Claudia C. Lasalle
David J. Ramsey
author_sort Oluchukwu Onwuka
collection DOAJ
description This study investigated whether the interval of monitoring at-risk, fellow eyes of patients with unilateral neovascular age-related macular degeneration (nAMD) has any bearing on the severity of the disease at the time of diagnosis. The study comprised a retrospective, cross-sectional comparative case series of treatment-naïve eyes in patients who were diagnosed sequentially with nAMD. We compared the visual acuity (VA) and central macular thickness (CMT) of patients who were actively receiving intravitreal injections (IVIs) of anti-vascular endothelial growth factor (anti-VEGF) agents at the time of second eye diagnosis with the VA and CMT of patients who had ceased treatment in their first eye because of reaching end-stages of disease. Intervals of visits and frequency of monitoring the macula of fellow eyes by means of optical coherence tomography (OCT) were abstracted from the medical record. We found that the at-risk fellow eyes of patients who had stopped treatment for nAMD in their first eye prior to fellow eye conversion were monitored significantly less frequently than the fellow eyes of patients who continued to receive treatment at the time of second eye diagnosis. Despite less frequent monitoring, VA and CMT were similar at the time of fellow eye diagnosis for both groups.
first_indexed 2024-03-11T08:32:58Z
format Article
id doaj.art-ee412c8e7a654d448805976c04c4d4dc
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T08:32:58Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-ee412c8e7a654d448805976c04c4d4dc2023-11-16T21:40:33ZengMDPI AGLife2075-17292023-01-0113238510.3390/life13020385Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular DegenerationOluchukwu Onwuka0Jackson L. Saddemi1Fatma Sema Akkan Aydoğmuş2Claudia C. Lasalle3David J. Ramsey4Department of Surgery, Division of Ophthalmology, Lahey Hospital and Medical Center, Beth Israel Lahey Health, Burlington, MA 01805, USADepartment of Surgery, Division of Ophthalmology, Lahey Hospital and Medical Center, Beth Israel Lahey Health, Burlington, MA 01805, USADepartment of Surgery, Division of Ophthalmology, Lahey Hospital and Medical Center, Beth Israel Lahey Health, Burlington, MA 01805, USADepartment of Surgery, Division of Ophthalmology, Lahey Hospital and Medical Center, Beth Israel Lahey Health, Burlington, MA 01805, USADepartment of Surgery, Division of Ophthalmology, Lahey Hospital and Medical Center, Beth Israel Lahey Health, Burlington, MA 01805, USAThis study investigated whether the interval of monitoring at-risk, fellow eyes of patients with unilateral neovascular age-related macular degeneration (nAMD) has any bearing on the severity of the disease at the time of diagnosis. The study comprised a retrospective, cross-sectional comparative case series of treatment-naïve eyes in patients who were diagnosed sequentially with nAMD. We compared the visual acuity (VA) and central macular thickness (CMT) of patients who were actively receiving intravitreal injections (IVIs) of anti-vascular endothelial growth factor (anti-VEGF) agents at the time of second eye diagnosis with the VA and CMT of patients who had ceased treatment in their first eye because of reaching end-stages of disease. Intervals of visits and frequency of monitoring the macula of fellow eyes by means of optical coherence tomography (OCT) were abstracted from the medical record. We found that the at-risk fellow eyes of patients who had stopped treatment for nAMD in their first eye prior to fellow eye conversion were monitored significantly less frequently than the fellow eyes of patients who continued to receive treatment at the time of second eye diagnosis. Despite less frequent monitoring, VA and CMT were similar at the time of fellow eye diagnosis for both groups.https://www.mdpi.com/2075-1729/13/2/385neovascular age-related macular degenerationanti-vascular endothelial growth factorchoroidal neovascularizationoptical coherence tomographyvisual acuity
spellingShingle Oluchukwu Onwuka
Jackson L. Saddemi
Fatma Sema Akkan Aydoğmuş
Claudia C. Lasalle
David J. Ramsey
Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
Life
neovascular age-related macular degeneration
anti-vascular endothelial growth factor
choroidal neovascularization
optical coherence tomography
visual acuity
title Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
title_full Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
title_fullStr Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
title_full_unstemmed Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
title_short Consequences of Real-World Surveillance of Fellow Eyes in Neovascular Age-Related Macular Degeneration
title_sort consequences of real world surveillance of fellow eyes in neovascular age related macular degeneration
topic neovascular age-related macular degeneration
anti-vascular endothelial growth factor
choroidal neovascularization
optical coherence tomography
visual acuity
url https://www.mdpi.com/2075-1729/13/2/385
work_keys_str_mv AT oluchukwuonwuka consequencesofrealworldsurveillanceoffelloweyesinneovascularagerelatedmaculardegeneration
AT jacksonlsaddemi consequencesofrealworldsurveillanceoffelloweyesinneovascularagerelatedmaculardegeneration
AT fatmasemaakkanaydogmus consequencesofrealworldsurveillanceoffelloweyesinneovascularagerelatedmaculardegeneration
AT claudiaclasalle consequencesofrealworldsurveillanceoffelloweyesinneovascularagerelatedmaculardegeneration
AT davidjramsey consequencesofrealworldsurveillanceoffelloweyesinneovascularagerelatedmaculardegeneration